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Summary The clinical diagnosis of cardiac sarcoidosis can be elusive, because the clinical
manifestations are non-speciﬁc, and the sensitivity and speciﬁcity of diagnostic modalities are
limited. A 60-year-old woman suffered atrial ﬂutter and diffuse thickening of the left atrialCorticosteroids wall accompanied with gallium-67 uptake, both of which were successfully treated with corti-
costeroid therapy. The diagnosis of cutaneous sarcoidosis had been made two years previously;
therefore, we diagnosed the patient as having atrial involvement of cardiac sarcoidosis, and
discuss here the importance of noninvasive evaluation of cardiac sarcoidosis using echocardio-
graphy.
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Introduction
Sarcoidosis is a granulomatous disease that may involve
multiple organ systems, including the heart. Cardiac
involvement in patients with sarcoidosis includes a variety
of clinical manifestations, such as advanced heart block,
malignant ventricular arrhythmias, mitral regurgitations,
pericarditis, congestive heart failure, and cardiac sud-
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en death. Although supraventricular arrhythmias are less
ommon than ventricular arrhythmias in patients with car-
iac sarcoidosis, electrocardiography in this case conﬁrmed
trial ﬂutter with complete right bundle branch block, which
isappeared after corticosteroid therapy. Atrial involvement
y sarcoid granuloma and the electrophysiological presenta-
ion are discussed in this report.ase report
60-year-old womanwas admitted to our hospital with exer-
ional dyspnea and palpitation. The patient’s diagnosis had
Published by Elsevier Ireland Ltd. All rights reserved.
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aigure 1 (A) Electrocardiography upon admission showing w
0mg of adenosine triphosphate disodium disclosed F waves of a
C) Electrocardiography after 30 days of steroid therapy showineen established two years previously as sarcoidosis with
kin involvement by a cutaneous biopsy specimen; whereas,
he patient never had clinical manifestations associated
ith cardiac sarcoidosis. Physical examinations at admis-
ion were a regular pulse of 128 bpm, blood pressure of
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igure 2 (A) Transthoracic echocardiography showing abnormal
chogenicity. (B) Transesophageal echocardiography clearly showin
eptum. (C) A marked increase in myocardial gallium-67 uptake (arrow
orta; LA, left atrium; LV, left ventricle; RA, right atrium.RS tachycardia at 128 bpm. (B) Intravenous bolus injection of
ﬂutter accompanied with complete right bundle branch block.
ular sinus rhythm with right bundle branch block.10/80mmHg, and a pansystolic regurgitant murmur con-
istent with mitral regurgitation. Chest auscultation was
lear, the liver was not palpable, and no edema of the
xtremities was observed. Chest radiographs showed car-
iomegaly with clear lung ﬁelds and a normal mediastinum.
thickening (arrows) of the left atrial posterior wall with low
g notable left atrial thickening (arrows) involving the atrial
s) was detected in planar and horizontal images. Ao, ascending
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wFigure 3 (A) Transthoracic echocardiography after 16 weeks o
face of the left atrial posterior wall. (B) Absence of myocardial u
therapy. LA, left atrium; LV, left ventricle.
Electrocardiography conﬁrmed sustained atrial ﬂutter with
2:1 atrioventricular conduction and complete right bun-
dle branch block (Fig. 1). Transthoracic echocardiography
showed left ventricular dysfunction with ejection fraction of
25%, while left ventricular size was normal and wall thick-
ness was at the upper limit of 12mm with no segmental
abnormalities. The right ventricle was mildly dilated with
normal systolic function. Moderate biatrial enlargement,
moderate mitral regurgitation, and mild tricuspid regurgi-
tation were observed. The peak systolic tricuspid pressure
gradient was 30mmHg. Interestingly, the left atrial posterior
wall was thickened to a maximal diameter of 3mm (Fig. 2).
These ﬁndings suggested cardiac involvement of sarcoidosis;
therefore, we performed transesophageal echocardiography
to further assess the atrium. It was remarkable that all
surfaces of the left atrial wall involving the atrial septum
were uniformly thickened with low echogenicity compared
with adjacent structures (Fig. 2). We initially considered the
thickened layer to reﬂect a thrombus on the atrial wall.
The patient was started on anticoagulation therapy with
warfarin potassium; however, 14 days of this strategy did
not have any impact on the echocardiographic abnormali-
ties of the atrial wall. Meanwhile, we systemically evaluated
the disease activity of sarcoidosis using gallium-67 scintig-
raphy, and found a marked increase in myocardial uptake
(Fig. 2). No features of pulmonary sarcoidosis were evident
on computed tomography scans, and coronary angiograms
appeared normal. Thus, we ﬁnally diagnosed the patient
as having cardiac sarcoidosis, based on the following: pre-
vious pathohistological evidence of cutaneous sarcoidosis,
a marked increase in myocardial gallium-67 uptake, and
electrocardiographic and echocardiographic abnormalities.
The patient was, therefore, started on oral prednisolone at
30mg per day, which resulted in a successful elimination
of the atrial ﬂutter in 30 days, and then electrocardio-
gram demonstrated sinus rhythmwith complete right bundle
branch block (Fig. 1). In addition, the abnormal myocardial
gallium-67 uptake also disappeared (Fig. 3). After 16 weeks
of steroid therapy, the patient was free from the recurrence
of atrial ﬂutter; moreover, transthoracic echocardiography
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articosteroid therapy showing normal thickness and smooth sur-
e on gallium-67 scintigraphy following 30 days of corticosteroid
evealed resolution of the thickening of the left atrial pos-
erior wall (Fig. 3).
iscussion
arcoidosis is a granulomatous disease that can involve
ultiple organ systems. Clinical manifestations of car-
iac sarcoidosis include advanced atrioventricular block,
ife-threatening ventricular arrhythmias, congestive heart
ailure, and sudden cardiac death. A variety of echocar-
iographical abnormalities has been reported including:
eft ventricular systolic dysfunction, segmental wall thin-
ing, ventricular aneurysm, and valvular abnormalities [1].
oberts et al. [2] examined 113 necropsies of patients, who
ied of cardiac sarcoidosis, and reported that granulomas
re most frequently located in the left ventricular free
all (96%), followed by the interventricular septum (73%);
hereas, the atrial wall is rarely affected (right, 11%; left,
%). Hourigan et al. reported a patient with atrial involve-
ent of cardiac sarcoidosis conﬁrmed after surgery by a
istological examination of the left atrial appendage [3].
lthough our patient had no evidence of cardiac pathohis-
ology, the thickening of the atrial wall was similar to the
atter report.
Supraventricular arrhythmias, including atrial ﬂutter, are
ess frequent than ventricular arrhythmias among patients
ith sarcoidosis, with an incidence of up to 19% [4].
n this case, atrial localization of either sarcoid gran-
lomas, inﬂammatory cell inﬁltration, or edema were
otentially involved in the pathophysiology of the atrial
utter with right bundle branch block, because sustained
trial ﬂutter and myocardial gallium-67 uptake concomi-
antly disappeared, and subsequently atrial wall thickening
as normalized following corticosteroid therapy. However,
e could not clearly conclude the mechanism of the atrial
utter, because we did not perform electrophysiological
tudy and did not obtain any relevant evidence of the
elation between atrial ﬂutter and cardiac sarcoidosis. In
ddition, corticosteroid therapy may modulate left ventric-
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lar function and result in the termination of the atrial
utter. It is sometimes difﬁcult to evaluate abnormalities on
he whole atrial wall due to the limitation of transthoracic
chocardiography. Here, we report a successful transtho-
acic detection of atrial sarcoid lesion, and would also like
o note the importance of a careful look at the whole heart
nd of less invasive strategies for diagnosis and treatment
or patients with cardiac sarcoidosis.
Although there has been no curative treatment for
arcoidosis, corticosteroids remain the mainstay of treat-
ent for patients with cardiac sarcoidosis [5]. Reports
ave demonstrated that corticosteroids relieve symptoms,
uppress inﬂammation and progression of ﬁbrosis, pre-
ent further deterioration in myocardial function, and
rovide a good prognosis [6,7]. To date, cardiac sarcoido-
is is regarded an absolute indication for corticosteroid
herapy.
This is the ﬁrst report of noninvasive diagnosis and
reatment of atrial involvement of cardiac sarcoidosis,
hich was detected by transthoracic echocardiography. This
eport may encourage echocardiologists to carefully look
t the atrium of either patients with systemic sarcoido-
is or anyone who requires differential diagnosis of cardiac
arcoidosis.
[S.-i. Aso et al.
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